Cancer of the Mouth and Throat (cont.)
IN THIS ARTICLE
Mouth and Throat Cancer Targeted Therapy
Targeted therapy, in which a drug is given that is specially designed to target molecules specific to the particular type of cancer, may be administered or combined with other therapies in some cases. Cetuximab and several other new treatments are available for targeted oral cancer therapy. These treatments are often used in conjunction with older forms of chemotherapy and radiation therapy. For example, Cetuximab (Erbitux) is an engineered antibody that binds to the epidermal growth factor receptor, a molecule important for cell growth. It was the first targeted therapy approved for oral cancer. Cetuximab binds to oral cancer cells and interferes with cancer cell growth and the spread of cancer. Cetuximab is given once a week in an injection through a vein (intravenous injection). It may cause certain unique side effects, including an acne-like rash. Today there are numerous other targeted agents being studied for use against squamous cell carcinomas of the head and neck, as well as against other forms of cancer which can arise elswere in the body.
Medically Reviewed by a Doctor on 11/3/2014
Must Read Articles Related to Cancer of the Mouth and Throat
Patient Comments & Reviews
The eMedicineHealth doctors ask about Cancer of the Mouth and Throat:
Mouth and Throat Cancer - Symptoms
What are the symptoms of your mouth and throat cancer?
Mouth and Throat Cancer - Diagnosis
How was your mouth and throat diagnosed?
Mouth and Throat Cancer - Treatment
What was the treatment for your mouth and throat cancer?